UK markets open in 2 hours 32 minutes

Genmab A/S (GNMSF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
355.30+3.90 (+1.11%)
At close: 03:42PM EDT
Full screen
Loading interactive chart…
  • Globe Newswire

    Major Shareholder Announcement

    Company Announcement Major shareholder announcement for Genmab A/S COPENHAGEN, Denmark; October 5, 2022 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Wellington Management Group LLP has informed us that, as of October 4, 2022, Wellington Management Group LLP through shares and financial instruments holds the voting rights to 3,309,527 shares in Genmab A/S, which amounts to 5.03% of the share capital and voting rights in Genmab A/S. Abo

  • Globe Newswire

    Capital Increase in Genmab as a Result of Employee Warrant Exercise

    Company Announcement COPENHAGEN, Denmark; September 27, 2022 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 18,406 shares as a consequence of the exercise of employee warrants. The increase is effected without any preemption rights for the existing shareholders of the company or others. The shares are subscribed in cash at the following price per share of nominally DKK 1: 133 shares at DKK 815.50,3,874 shares at DKK 939.50,367 shares at DKK 962.00,8,949 shares at DKK 1,025.00,878

  • Globe Newswire

    Grant of Restricted Stock Units and Warrants to Employees in Genmab

    Company Announcement COPENHAGEN, Denmark; September 20, 2022 – Genmab A/S (Nasdaq: GMAB) announced today that the board decided to grant 19,782 restricted stock units and 19,789 warrants to employees of the Company and the Company's subsidiaries. Each restricted stock unit is awarded cost-free and provides the owner with a right and obligation to receive one share in Genmab A/S of nominally DKK 1. The fair value of each restricted stock unit is equal to the closing market price on the date of gr